Statistics for Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
Total visits
| views | |
|---|---|
| Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial | 9 |
Total visits per month
| views | |
|---|---|
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 1 |
| October 2026 | 2 |
| November 2026 | 0 |
File Visits
| views | |
|---|---|
| SAFETY~1.PDF | 312 |
Top country views
| views | |
|---|---|
| Chile | 4 |
| Argentina | 1 |
| Egypt | 1 |
| Hong Kong SAR China | 1 |
| Singapore | 1 |
| United States | 1 |
Top city views
| views | |
|---|---|
| Santiago | 4 |
| Cairo | 1 |
| La Plata | 1 |
| Pittsburgh | 1 |
| Singapore | 1 |